Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
neeraj agarwal
Apr 30, 2024, 10:34 |
Blog
Neeraj Agarwal: Validation of Molecular Clusters in JAVELIN Renal 101 Dataset: Commentary by Chadi Hage Chehade
Neeraj Agarwal shared a post on X: "Just in Cancer Cell. Validation of the molecular clusters…
Apr 27, 2024, 11:23 |
Insight
APCCC24 Highlights: Lutetium-177 PSMA RLT Toxicity Management by Neeraj Agarwal
Neeraj Agarwal shared on X/Twitter: "How to monitor and manage toxicities with Lutetium-177 PSMA RLT? Luis…
Apr 27, 2024, 09:53 |
Blog
Neeraj Agarwal: Advanced Prostate Cancer Consensus Conference, Fantastic talk by Neha Vapiwala on radiation therapy in high risk Prostate Cancer
Neeraj Agarwal shared on X/Twitter: "Advanced Prostate Cancer Consensus Conference, Fantastic talk by Neha Vapiwala on radiation…
Apr 23, 2024, 16:51 |
Insight
Neeraj Agarwal: Full protocol of our trial of creatine supplementation and resistance training in advanced prostate cancer undergoing ADT
Neeraj Agarwal shared on X: "Just in BioMed Central! Full protocol of our recently initiated,…
Apr 15, 2024, 12:07 |
Blog
Neeraj Agarwal: A comprehensive review of PARPi+ARPI combos in 1st line mCRPC
Neeraj Agarwal shared a post on X: "Just in A comprehensive review of PARPi+ARPI combos…
Apr 14, 2024, 14:15 |
Insight
Neeraj Agarwal: Data from SWOG 1216 trial in mHSPC
Neeraj Agarwal shared on X/Twitter: "Just in: Data from SWOG Cancer Research Network 1216 trial…
Dec 5, 2023, 19:09 |
Insight
Neeraj Agarwal: Results from Ph3 TALAPRO-2 trial in 399 pts w/ HRR-deficient mCRPC prostate cancer
Neeraj Agarwal shared the following on Twitter: “Just in Nature Medicine: Results from Ph3 TALAPRO-2…
Nov 9, 2023, 19:17 |
Opinion
Vivek Subbiah: Feeling grateful to have a brilliant and forward-thinking global expert in GU as a close friend Neeraj Agarwal
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted the following…
Aug 22, 2023, 09:55 |
Drugs
Neeraj Agarwal: Breaking news: Glad to report the news from ph3 Contact-2 trial Cabozantinib + atezolizumab significantly improved outcomes in mCRPC prostate cancer.
Neeraj Agarwal stated on Twitter: "Breaking news: Glad to report the news from ph3 Contact-2 trial…
Jul 14, 2024, 06:27 |
Blog
Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
2
3
4
5
6
All:
85
Posts:
31 - 40
43 Posts Not To Miss From ESMO24 Day 2
45 Posts not to miss from ESMO24 Day 1
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube